Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Envoy Medical (COCH) Change in Cash (2022 - 2025)

Historic Change in Cash for Envoy Medical (COCH) over the last 4 years, with Q3 2025 value amounting to -$1.7 million.

  • Envoy Medical's Change in Cash fell 16463.78% to -$1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$868000.0, marking a year-over-year increase of 9300.9%. This contributed to the annual value of $1.3 million for FY2024, which is 6864.93% down from last year.
  • Envoy Medical's Change in Cash amounted to -$1.7 million in Q3 2025, which was down 16463.78% from -$25000.0 recorded in Q2 2025.
  • Over the past 5 years, Envoy Medical's Change in Cash peaked at $16.8 million during Q3 2023, and registered a low of -$12.6 million during Q4 2023.
  • In the last 4 years, Envoy Medical's Change in Cash had a median value of -$25000.0 in 2025 and averaged $162333.3.
  • Within the past 5 years, the most significant YoY rise in Envoy Medical's Change in Cash was 419410.73% (2023), while the steepest drop was 286291.08% (2023).
  • Quarter analysis of 4 years shows Envoy Medical's Change in Cash stood at -$426000.0 in 2022, then crashed by 2862.91% to -$12.6 million in 2023, then surged by 108.39% to $1.1 million in 2024, then crashed by 263.46% to -$1.7 million in 2025.
  • Its Change in Cash was -$1.7 million in Q3 2025, compared to -$25000.0 in Q2 2025 and -$171000.0 in Q1 2025.